Integrating Quality of Life and Survival Outcomes Cardiovascular Clinical Trials: Results From the PARTNER Trial (vol 12, e005420, 2019)

被引：0

|

作者：

Spertus

机构：

来源：

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2019年 / 12卷 / 09期

关键词：

D O I：

10.1161/HCQ.0000000000000058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 37 条

[31] Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin
Loftus, Jane
Quitmann, Julia
Valluri, Srinivas Rao
CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (02) : 175 - 184
[32] The impact of adjuvant vinorelbine (VIN) and cisplatin (CIS) on quality of life (QoL): Results from The National Cancer Institute of Canada Clinical Trials Group Trial BR.10 randomized trial of VIN/CIS versus observation in stage IB and II non-small cell lung cancer (NSCLC)
Shepherd, F.
Winton, T.
Livingston, R.
Johnson, D.
Rigas, J.
Cormier, Y.
Bezjak, A.
Ding, K.
Graham, B.
Seymour, L.
ANNALS OF ONCOLOGY, 2004, 15 : 165 - 166
[33] Comparison of Outcomes at Time of Superior Cavopulmonary Connection Between Single Ventricle Patients With Ductal-Dependent Pulmonary Blood Flow Initially Palliated With Either Blalock-Taussig Shunt or Ductus Arteriosus Stent: Results From the Congenital Catheterization Research Collaborative (vol 12, e008110, 2019)
Meadows
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (11)
[34] Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial
Litzow, Mark R.
Sun, Zhuoxin
Paietta, Elisabeth
Mattison, Ryan J.
Lazarus, Hillard M.
Rowe, Jacob M.
Arber, Daniel A.
Mullighan, Charles G.
Willman, Cheryl L.
Zhang, Yanming
Wieduwilt, Matthew
Liedtke, Michaela
Bergeron, Julie
Pratz, Keith W.
Dinner, Shira
Frey, Noelle, V
Gore, Steven D.
Bhatnagar, Bhavana
Atallah, Ehab L.
Uy, Geoffrey L.
Jeyakumar, Deepa
Lin, Tara L.
Little, Richard F.
Luger, Selina M.
Tallman, Martin S.
BLOOD, 2022, 140 : 1 - 4
[35] Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups (vol 115, pg e478, 2007)
Adams
CIRCULATION, 2007, 116 (18) : E515 - E515
[36] Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study (vol 6, pg e89, 2019)
Bonifazi, F.
Solano, C.
Wolschke, C.
LANCET HAEMATOLOGY, 2019, 6 (03): : E121 - E121
[37] Comparable survival in newly diagnosed multiple myeloma (MM) after VAD induction with high dose therapy using melphalan 140mg/m2 + TBI 12 Gy (MEL+TBI) versus standard therapy with VBMCP and no benefit from interferon (IFN) maintenance:: Final clinical results of intergroup trial S9321 in the context of IFM 90 and MRC VII trials.
Crowley, J
Fonseca, R
Greipp, P
McCoy, J
Barlogie, B
BLOOD, 2004, 104 (11) : 156A - 157A

← 1 2 3 4 →